GAM
ACHN

Gotham Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Gotham Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-191,792
Closed -$1.5M – 1099
2016
Q2 		$1.5M Sell
191,792
-362,333
-65% -$3.11M 0.02% 573
2016
Q1 		$4.28M Buy
+554,125
New +$4.06M 0.05% 458

Other funds holding ACHN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gotham Asset Management's ACHN Position: Q3 2016 in Review

Gotham Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q3 2016, closing a stake of 191,792 shares — an estimated $1.5M sold.

Gotham Asset Management first reported a position in ACHN in Q1 2016 and held it in 2 quarters. The position peaked at $4.28M in Q1 2016. 162 funds tracked by Wall St. Rank hold ACHN as of Q3 2016.

  • Gotham Asset Management reported no remaining Achillion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Gotham Asset Management sold 191,792 Achillion Pharmaceuticals shares in Q3 2016, an estimated $1.5M.
  • Gotham Asset Management first reported a position in Achillion Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Gotham Asset Management's Achillion Pharmaceuticals position peaked at $4.28M in Q1 2016.
  • 162 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2016.

Based on Gotham Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.